| Singh V, Cardoso N, Huszar S (2023*) " Chemotherapy for Drug - suscetible Tuberculosis, pages 229-255. |
| P.N. Njogu, J. Okombo and K. Chibale* (2017), ‘Designed hybrid compounds for tropical parasitic diseases.” In: Hybrid Molecules for Drug Development. Chapter 4, pages 83-135. Edited by M. Decker.© 2017 Elsevier Ltd. |
|
P.N. Njogu and K. Chibale* (2014), ‘Current and future strategies for improving drug discovery efficiency. In: XX, eds. Alexander, A., Smith, D.A.; Harris, C.J., X: country (2014), in press. |
|
E. Pavadai and K. Chibale (2014), ‘Practical Aspects of Building, Validation and Application of 3D-Pharmacophore Models. In: Chemometrics Applications and Research: QSAR in Medicinal Chemistry, eds. A.G. Mercader, P R. Duchowicz, P. M. Sivakumar |
|
N.T. L Chigorimbo-Murefu, G. Mugumbate and K. Chibale* (2014), ‘Enabling Technologies to facilitate natural product-based drug discovery from African Biodiversity. In: Novel Plant Bioresources: applications in food, medicine & cosmetics, eds. Gurib-Fakim, A., 2014 by John Wiley & Sons Ltd Wiley, UK. ISBN 978-1-118-46061-0 (cloth) |
|
A. Nzila and K. Chibale. (2012) ‘Anticancer drug repositioning against tropical diseases: the example of methotrexate in the treatment of malaria’. In: Drug Discovery in Africa, eds. Chibale K., Masimirembwa C. and Davies-Coleman, M., Springer: Germany (2012). |
|
E. M. Guantai and K. Chibale. (2012) ‘Natural product-based drug discovery in Africa: the need for integration into modern drug-discovery paradigms. In: Drug Discovery in Africa, eds. Chibale K., Masimirembwa C. and Davies-Coleman, M., Springer: Germany (2012). |
|
Contributed to World Health Organization (WHO), Geneva, Switzerland, book chapter entitled "Enabling innovation” prepared for publication in the book entitled "Combating Antimicrobial Resistance: Experiences from the Field" planned to appear as a WHO book publication in 2011. |